By G HossainPosted on November 13, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Windward Bio’s public debut brings this year’s IPO count well above the sluggish total of eight in 2025. Windward nets $175M IPO, bringing 2026 biotech debuts to 35 Post navigation Regeneron’s POTS antibody curbs heart rate spikes, teeing up Phase 3 trialArrowhead’s Ionis problem, Kyverna’s next-gen end and more biotech earnings
